# BASF Corporation - Inspection Records

Source: https://www.keypedia.com/companies/basf-corporation/66c1d1cd-8b92-4631-b68d-5e8932ea9c42

> Inspection records and compliance data for BASF Corporation in Geismar, Louisiana. Access full analysis and detailed observations.

---

## Details

- Name: BASF Corporation
- FEI Number: 2316568
- City: Geismar
- State: Louisiana
- Country Name: United States
- Address Line 1: 8404 Highway 75
- Zip Code: 70734
- Business Operations: API MANUFACTURE

## Related Documents

- [483 - BASF Corporation - 2024-07-22](https://www.keypedia.com/records/483/basf-corporation/62f464e2-49f9-4484-b12c-1d3b480f7034) — source: FDA, date: July 22, 2024
- [FDA Inspection 1231003 - BASF Corporation - 2024-07-22](https://www.keypedia.com/records/fda_inspections/basf-corporation/c925c9ee-1126-4e69-9922-5e5a28577d1d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 22, 2024
- [FDA Inspection 1130587 - BASF Corporation - 2020-09-17](https://www.keypedia.com/records/fda_inspections/basf-corporation/b19dfba4-1d37-40de-9038-0d03cdbf422e) — classification: No Action Indicated (NAI), source: FDA, date: September 17, 2020
- [FDA Inspection 1070220 - BASF Corporation - 2018-10-09](https://www.keypedia.com/records/fda_inspections/basf-corporation/faecbf13-7397-42d3-8518-78a3a96a3667) — classification: No Action Indicated (NAI), source: FDA, date: October 9, 2018
- [FDA Inspection 1070220 - BASF Corporation - 2018-10-09](https://www.keypedia.com/records/fda_inspections/basf-corporation/90bfd8d9-e8eb-470d-8b2e-bc4c4f926ee3) — classification: No Action Indicated (NAI), source: FDA, date: October 9, 2018
- [FDA Inspection 980496 - BASF Corporation - 2016-07-14](https://www.keypedia.com/records/fda_inspections/basf-corporation/a0383221-1368-4861-a88a-2fc647939b09) — classification: No Action Indicated (NAI), source: FDA, date: July 14, 2016
- [FDA Inspection 866852 - BASF Corporation - 2014-02-20](https://www.keypedia.com/records/fda_inspections/basf-corporation/26e18f67-7e8f-48af-9304-d6f627eea778) — classification: No Action Indicated (NAI), source: FDA, date: February 20, 2014

## Related Companies

- [Strem Chemicals, Inc.](https://www.keypedia.com/companies/strem-chemicals-inc/285a934f-0fb3-4204-8233-4b3fc4364d64)
- [ISP Chemicals LLC](https://www.keypedia.com/companies/isp-chemicals-llc/8523c955-e979-40c7-afae-92f881ffe0d0)
- [Albemarle US, Inc.](https://www.keypedia.com/companies/albemarle-us-inc/336600a7-808b-4d7d-bfc0-7a9e728aa0aa)
- [Cadila Pharmaceuticals Limited](https://www.keypedia.com/companies/cadila-pharmaceuticals-limited/042118cf-4e9b-432b-b155-94c2b5e3e025)
- [Natco Pharma Ltd. - Chemical Division](https://www.keypedia.com/companies/natco-pharma-ltd-chemical-division/3d56c2ac-4a7d-4f9f-8987-966d0ff5e5f1)
- [Zhejiang Cheng Yi Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/zhejiang-cheng-yi-pharmaceutical-co-ltd/dabc68a0-9969-418a-9cd6-54e9987ed8df)
- [Wuhan Biocause Pharmaceutical Development Co., Ltd.](https://www.keypedia.com/companies/wuhan-biocause-pharmaceutical-development-co-ltd/79c352a3-22a2-471e-abbe-1802683656eb)
- [BCN Peptides SA](https://www.keypedia.com/companies/bcn-peptides-sa/b0fa0b1d-5597-4653-9d34-ae9ab14d2de3)
- [Huber Soda, LLC](https://www.keypedia.com/companies/huber-soda-llc/89d2a595-ba2c-46a2-987c-65bb21b1b75b)
- [Guangzhou Hanpu Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/guangzhou-hanpu-pharmaceutical-co-ltd/aa9e3246-019e-49cc-b473-391a75a82fd2)

## Related Officers

- [Medical Officer at FDA](https://www.keypedia.com/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)